| |
The Journal of the Formosan Medical Association is the peerreviewed
publication of the Formosan Medical Association,
based
in Taipei, Taiwan. The JFMA invites original contributions
relating to all fields of medicine and related disciplines that are
of interest to the medical profession.
Manuscript Submission
Online submission
The JFMA accepts online
submission of manuscripts through
Elsevier's Editorial System (EES). This system can be accessed at  http://ees.elsevier.com/jfma/
This site will guide authors stepwise through the submission process. Contact the JFMA Editorial Office for any help necessary.
Other methods of submission
If you are unable to submit your manuscript via the EES, you may submit your manuscript and
figures as e-mail attachments to the JFMA Editorial Office at: jfmaed@fma.org.tw.
Alternatively, you can
submit your manuscript on a 3.5" floppy
disk or CD-R and post it, together with four hard copies of your
manuscript (that matches the
disk file exactly) and a cover letter
(that includes your name, address, telephone and fax numbers,
and e-mail address), to:
Editorial
Office
Journal of the Formosan Medical Association
1, Chang-Te Street
Taipei 100, Taiwan.
If there are figures,
please also enclose four sets of the original
figures to the Editorial Office at the above address. They will not
be returned. (Please
note that authors will be charged NT$2500
per color illustration.)
Manuscripts may also be submitted directly to the North
American Regional Editor at:
T.-C. Wu, MD, PhD
JFMA Regional Editor (North America)
Professor, Departments of Pathology,
Oncology, Obstetrics
and Gynecology, and Molecular Microbiology and
Immunology, The Johns Hopkins Medical Institutions,
CRB
II Room 309, 1550 Orleans Street,
Baltimore, MD 21231, USA.
Tel: (+1) (410) 614-3899; Fax: (+1) (443) 287-4295
E-mail: wutc@jhmi.edu
Manuscript file requirements
• The complete manuscript should be in one Microsoft Word
document (*.doc) file. The manuscript
should include the
following: title page, abstract, key words, main text, acknowledgments,
references, tables and table headings, and
figure
legends
• Each figure should be submitted as a separate high resolution
picture file, in *.EPS or *.TIFF format. Please
ensure that
files are supplied at the correct resolution of a minimum of
600 dpi
Previous Publication / Duplicate Submission
Submitted manuscripts are considered with the understanding
that they have not been published previously in print or electronic
format
(except in abstract or poster form) and are not
under consideration by another publication or electronic
medium.
Disclosure of
Conflicts of Interest
All authors are required to sign and submit the following financial
disclosure statement at the time of
manuscript submission:
- I certify that all my affiliations with or financial involvement
in, within the past 5 years and foreseeable
future, any organization
or entity with a financial interest in or financial conflict
with the subject matter or materials discussed
in the manuscript
are completely disclosed (e.g. employment, consultancies,
honoraria, stock ownership or options, expert testimony,
grants
or patents received or pending, royalties).
Authors who have no relevant financial interests should provide
a statement
indicating that they have no financial interests
related to the material in the manuscript.
Basic Criteria
Articles should
be written in English (using American English
spelling) and meet the following basic criteria: the material is
original, the information
is important, the writing is clear
(clinical or laboratory jargon is to be avoided), the study methods
are appropriate, the data are
valid, and the conclusions are
reasonable and supported by the data.
Article Categories
The categories of articles that
are published are:
- original articles
- case reports
- clinical notes
- brief communications of work in progress
- letters to the editor
- news and perspectives
- review articles (by invitation only)
For residents of Taiwan, at least one
author must be a member
of the Formosan Medical Association, except for those who have
been invited to contribute.
Manuscript Preparation
The format of manuscripts for the JFMA must comply with the 5th
edition of the Uniform Requirements for Manuscripts Submitted
to Biomedical Journals (Ann Intern Med 1997;126:36.47).
Text, including tables, references and figure legends, should
be typed double-spaced
on one side of A4 (297 ~210mm) paper.
Pages should be numbered consecutively, beginning with the
title page. Arabic numbers should be
used.
Manuscripts should be prepared in the simplest form
possible. We will add in the correct font, font size, margins
and so on
according to our house style. You may use automatic
page numbering, but please do NOT use other kinds
of automatic formatting such as
footnotes, endnotes, headers
and footers.
While the following instructions are for original articles, they
apply generally to other
article categories also.
Title Page
The title page is the first page and must contain the following
information:
•
category of paper
• manuscript title
• short running title not exceeding 50 characters
• the names (spelled
out in full) of all the authors and their
institutions
• corresponding author details (e-mail address, mailing address,
telephone
and fax numbers)
• where applicable, authors' Chinese names, affiliations and
corresponding address should appear in Chinese
characters
below the English information
Abstract
The second page should contain a concise abstract of no more
than 300
words and up to 5 relevant key words in alphabetical
order for the purposes of cross-indexing. Abstracts should be
structured, with the
section headings:
• Background/Purpose: briefly explain the importance of the
study topic and state a precise study question
or purpose
• Methods: briefly introduce the methods used to perform
the study; include information on the study design, setting,
subjects, interventions, outcome measures and analyses
as appropriate
• Results: briefly present the significant results, with
data and
statistical details such as p values where appropriate; be sure
that information in the abstract matches that in the main text
• Conclusion: state the meaning of your findings, being careful
to address the study question directly and to confine your
conclusions to aspects covered in the abstract; give equal
emphasis to positive and negative findings
• Key Words: these should
be taken from the Medical Subject
Headings (MeSH) list of Index Medicus ( http://www.nlm.nih.gov/mesh/meshhome.html )
Abstracts for Case Reports and Brief Communications are unstructured,
but should nevertheless include information on the
background/purpose
of the report, methods, results (or case
report), and conclusions. Unstructured abstracts should be no
more than 200 words in length.
Main Text
The main text should begin on the third page and, for most
original articles, should include the following sections:
Introduction, Materials (or Patients or Subjects) and Methods,
Results, and Discussion. Subheadings in long papers are acceptable
if
needed for clarification and ease of reading.
The Introduction should address the subject of the paper.
The Materials and Methods
section should identify the population,
patient samples or animal specimens used, explain the
laboratory or study methods followed, and
state the statistical
procedures employed in the research. The Results section should
include pertinent findings and necessary tables
and figures.
The Discussion should contain conclusions based on the findings
of the study, a review of the relevant literature, a discussion
of the application of the conclusions and implications for future
research or clinical applications.
Following the Discussion, Acknowledgments
may be given.
Those acknowledged should not include secretarial, clerical or
technical staff whose participation was limited to the performance
of their normal duties.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations,
appropriate institutional
review board or ethics committee approval is required,
and such approval should be stated in the methods section
of the
manuscript. For those investigators who do not have formal ethics
review committees, the principles outlined in the Declaration
of
Helsinki should be followed (World Medical Association. Declaration
of Helsinki: ethical principles for medical research involving
human
subjects. Available at: http://www.wma.net/e/policy/pdf/17c.pdf ).
For investigations of human subjects, state
explicitly in the
methods section of the manuscript that informed consent was
obtained from all participating adult subjects and from
parents
or legal guardians for minors or incapacitated adults, together
with the manner in which informed consent was obtained (i.e.
oral or written).
Identification of Patients in Descriptions, Photographs, and
Pedigrees
A signed statement of informed
consent to publish (in print and
online) patient descriptions, photographs, and pedigrees should
be obtained from all persons (parents
or legal guardians for
minors) who can be identified (including by the patients themselves)
in such written descriptions, photographs,
or pedigrees,
and should be submitted with the manuscript. Such persons
should be shown the manuscript before its submission. Omitting
data or making data less specific to deidentify patients is acceptable,
but changing any such data is not acceptable.
Funding/Support
and Conflicts of Interest
All financial and material support for the research and the
work should be clearly and completely identified
in an
Acknowledgments in the manuscript. Ensure that any conflicts
of interest are explicitly declared.
Abbreviations
Abbreviations should be kept to a minimum. Where a term/
definition will be continually referred to, it must be written in
full, followed
by the subsequent abbreviation in brackets,
when it first appears in the abstract and text. Thereafter, the
abbreviation may be used.
Drug Names
Use the Recommended International Non-proprietary Name
(rINN) for medicinal substances, unless the specific trade
name
of a drug is directly relevant to the discussion.
Units
Please use the metric system for the expression of length,
height,
weight, mass, area and volume. Temperatures are to be given in
degrees Celsius. Please use Systeme International (SI) units for
all hematologic and clinical chemistry measurements, with the
exception of blood pressure values which are to be reported in
mmHg.
Personal Communications and Unpublished Data
A signed statement of permission should be included from each
individual identified
as a source of information in a personal
communication or as a source for unpublished data; the date of
communication and whether the
communication was written
or oral should be specified.
References
In general, the number of references should not exceed
50.
Authors are responsible for the accuracy and completeness of
their references and for correct text citation.
• Each reference
citation within the main body of the text
should be a superscript Arabic number
• References must be numbered consecutively
in order of
appearance in the text, and listed in number order in the
reference list: do not alphabetize
• References cited
in tables or figure legends should be included
in sequence at the point where the table or figure is
first mentioned in the text
•
Abstracts should not be cited unless the abstract is the only
available reference to an important concept
• Do not cite uncompleted
work or work that has not yet been
accepted for publication as references
• Do not cite references in the abstract of your
manuscript
• Abbreviations for journal titles should conform to those
used in Index Medicus
• References
should include the authors' last names and initials
(up to three authors, if more than three, then list only
three authors followed by
"et al"), complete title of the article,
journal name, year, volume number, and first and last
page numbers
• References to
books should include the authors' last names
and initials (up to three authors, if more than three, then
list only three authors followed
by "et al"), complete title
of the chapter, names of the book's editors, complete
title of the book, city of publication, publisher,
year of
publication and inclusive page numbers of the cited chapter;
volume and edition numbers should be included when
appropriate
•
If you must cite information from a website, please provide
the author information, article title, the website address and
the date
you accessed the information
• Direct quotations must be exact
• If the reference is in a language which does not
use the
Roman alphabet, it should be translated into English, and
the language of the original should appear in parentheses
following
the citation of the reference; if previously translated,
the translated article may be cited
Examples are given below.
Journal
articles:
1. Su DH, Chang YC, Chang CC. Post-traumatic anterior and posterior
pituitary dysfunction. J Formos Med Assoc
2005;104:463.7.
2. Su WP, Yang CH, Yu CJ, et al. Gefitinib treatment for non-small cell
lung cancer.a study including patients with
poor performance
status. J Formos Med Assoc 2005;104:557.62.
3. Kaplan NM. Coronary heart disease risk factors and antihypertensive
drug selection. J Cardiovasc Pharmacol 1982;4(Suppl 2):
S187.9.
4. World Health Organization. Immunoglobulin E: a new class
of human
immunoglobulin. Bull WHO 1968;38:151.2.
5. Anonymous. Neurovirulence of enterovirus 70. Lancet 1982;1:373.4.
[Editorial]
6. Shime N, Ono A, Chihara E, et al. Current status of pulmonary aspiration
associated with general anesthesia: a nationwide
survey in Japan.Masui 2005;54:1177.85. [In Japanese]
Books:
1. Plum F, Posner JB. The Diagnosis of
Stupor and Coma, 3rd edition.
Philadelphia: FA Davis, 1980:123.33.
2. Levinsky NG. Fluid and electrolytes. In: Thorn GW, Adams
RD,
Braunwald E, et al, eds. Harrison's Principles of Internal Medicine,
8th edition. New York: McGraw-Hill, 1977:364.75.
3.
Kurland LT. The epidemiologic characteristics of multiple sclerosis.
In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology,
Vol 9:
Multiple Sclerosis and Other Demyelinating Diseases. Amsterdam:
North-Holland Publishing, 1970:63.84.
Proceedings
and other publications:
1. Adams JH. Central pontine myelinolysis. In: Proceedings of the 4th
International Congress
of Neuropathology, 1961, Munich, Vol 3.
Stuttgart: Thieme, 1962:303.8.
2. Hung TP, Chiang TR. Multiple sclerosis in Taiwan:
clinical, electrophysiological
and epidemiological studies. In: 6th Asian and
Oceanian Congress of Neurology, 1983, Taipei. Asia
Pacific Congress
Series No 22. Hong Kong: Excerpta Medica, 1983:28. [Abstract]
3. Allen N, Burkholder JD, Molinari GF, et al.
Clinical criteria of brain
death. In: The NINCDS Collaborative Study of Brain Death. Bethesda:
National Institutes of Health,
1980:77.147. NIH publication 81-2286.
4. Cairns RB. Infrared Spectroscopic Studies of Solid Oxygen. Berkeley,
California:
University of California, 1965:156. [Dissertation]
5. Eastman Kodak Company. Eastman Organic Chemicals. Rochester,
NY: Eastman
Kodak Company, 1977:187. Catalog No 49.
6. Department of Health, Executive Yuan, Taiwan, R.O.C. Incidence of
Head Lice (Pediculus
capitis) Among School Children in Taiwan
Province, 1990. Taipei: Department of Health, Executive Yuan,
Taiwan, R.O.C.
Tables
Tables should be labeled in Arabic numerals and titled concisely.
Number all tables in the order of their citation in the text.
Tables
should be typed double-spaced in as simple a form as
possible. Abbreviations used in the table and not defined in the
text should be
defined in footnotes using these symbols (in order
of appearance): *,†, ‡, §, ||, ¶.
Figures
The number of figures should be restricted to the minimum
necessary to support the textual material. Figures should be labeled
in Arabic
numerals in the order of their citation in the
text. Figure legends should indicate the anatomic area and/or
pathologic condition shown.
For photomicrographs, include the
type of specimen, original magnification, and stain. All symbols
and abbreviations not defined in the
text should be defined in
the legend.
Each figure should be submitted as a separate high resolution
picture file, in *.EPS or *.TIFF
format. Please ensure that
files are supplied at the correct resolution of a minimum of
600 dpi.
If you are not submitting your manuscript
electronically
(i.e. not online by Author Gateway™ or by e-mail), then please
post four sets of the original figures to the JFMA
Editorial
Office. They will not be returned. The figures should be in the
form of unmounted, unretouched glossy prints (about 3.5"
in
size), and marked on the back with the figure number, an
arrow to indicate the top of the figure, and the first author's
name, using
a soft lead pencil or stick-on labels. Patient identification
should be obscured. Do not mark directly on the
prints. Indicators/arrows
and labels may be marked on a photocopy
of the original print to indicate subtle but salient
points. Include internal scale markers in
photomicrographs
and electron micrographs. Illustrations should be drawn with
black ink on white paper and should preferably be done
by a
professional illustrator. Arrows and other symbols must be of
professional quality and of a size permitting some reduction
in the
final copy.
Please note that authors will be charged NT$2500 per color
illustration.
Other Article Styles
News
and Perspectives
These are comments on recent news or groundbreaking work
and should provide a short review of the current state
of research
and explain the importance of the new findings. News and
Perspectives that are focused on papers published in the Journal
of the Formosan Medical Association should add a different viewpoint
to the research and should not merely be a repetitive
summary
of the original paper. Although many of the News and
Perspectives published in the Journal are solicited, we welcome
proposals from potential
authors. As these are meant to express
a personal commentary, with rare exceptions, News and Perspectives
should have no more than three
authors. The text
should not exceed 1000 words, with no more than one figure.
Review Articles
Review articles are critical
assessments of topical issues in research
or clinical practice. Systematic methods for inclusion of
all data sources and critical review
of those sources should be
described in the paper. The maximum length is 3500 words,
and the number of references should not exceed 100.
Articles by Invitation
The format for invited articles will be jointly decided by the
editorial board and the contributing
author.
Case Reports
Case reports should have no more than six authors. The abstract
should be no longer than 200 words
and should include statements
of the problem, clinical manifestations, methods of
treatment, and outcome. In the main body of the text,
the "Materials
and Methods" and "Results" sections should be replaced by
the "Case Report(s)" section, which should include statements
of the problem, patient history, diagnosis, treatment, results, and
any other information pertinent to the case(s). All other sections
should follow the format for original articles. The text should not exceed 2000 words and the number of references
should not exceed
25. Note that the rejection rate for case
reports is higher due to the current situation of a large number of
case reports being submitted.
Short case reports are encouraged
to be submitted under the category of "Correspondence". The
editorial board may request short case
reports to be formatted
as correspondence under most circumstances.
Brief Communications
Brief communications should have
no more than six authors and
should be concise presentations of clinical or technical notes, or
preliminary experimental results. The
abstract should be no
longer than 150 words. The main body of the text should not exceed
1500 words, with no more than two tables or
figures, and
no more than three illustrations. The number of references
should not exceed 20. The editors reserve the right to decide
what constitutes a Brief Communication.
Correspondence
These include short case reports, technical or clinical notes
and short comments on previously published articles. The
number of authors should not exceed 4. The text should not
exceed 500 words
and may include one table or figure and up
to 5 references. The editors reserve the right to decide what
constitutes a correspondence.
Letters to the Editor
Letters to the editor are welcome in response to articles previously
published in the JFMA.
They should be no more than
250 words long and may include one table or figure and up to
four references. The editors reserve the right
to edit any letter
received.
News and Perspectives
These are comments on recent news or groundbreaking work
and should
provide a short review of the current state of research
and explain the importance of the new findings. News and
Perspectives that are
focused on papers published in the Journal
of the Formosan Medical Association should add a different viewpoint
to the research
and should not merely be a repetitive
summary of the original paper. Although many of the News and
Perspectives published in the Journal
are solicited, we welcome
proposals from potential authors. As these are meant to express
a personal commentary, with rare exceptions,
News and Perspectives
should have no more than three authors. The text should
not exceed 1000 words, with no more than one figure.
Review Articles
Review articles are critical assessments of topical issues in research
or clinical practice. Systematic methods
for inclusion of
all data sources and critical review of those sources should be
described in the paper. The maximum length is 4000 words,
and
the number of references should not exceed 100. By invitation
only.
Articles by Invitation
The format for invited
articles will be jointly decided by the
editorial board and the contributing author.
Editorial and Peer Review
Submitted
manuscripts are reviewed initially by the Editorial
Board, who will determine which articles will be considered
for publication based
on their scientific merit, readability
and interest. Manuscripts with insufficient priority for publication
are rejected promptly. All
other manuscripts are sent to
two or more expert consultants for peer review. Authors may,
at the time of manuscript submission, also
submit a list of reviewers
who they wish to review or not to review their manuscript.
The board reserves the right to make revisions
to the
manuscript.
Preparation for Publication
It is a basic requirement that the manuscript be prepared ingood
English. The Editorial Office reserves the right to editpoor English as suggested by the reviewer(s) and/or Editorial
Board before
the final version is decided. The editing fee will
be charged to the authors. Once a manuscript has been accepted
for publication by
the Editorial Board and the final version is
approved by the authors, authors should submit the FINAL
VERSION of the manuscript
(in MS Word format) through the
method by which the manuscript was originally submitted,
i.e. via Author Gateway™ or e-mail (jfmaed@ntumc.org)
or by
post to the JFMA Editorial Office (save manuscript on 3.5"
floppy disk or CD-R and post, together with 2 paper copies
of
the manuscript that match the disk file exactly, to the JFMA
Editorial Office.)
All persons listed as authors should have
participated sufficiently
in the work to take public responsibility for the content,
and should have made substantial contributions to
all of the
following aspects of the work: (a) conception and design; (b)
analysis and interpretation of the data; (c) drafting the article
or revising it critically for intellectual content; and (d) final approval
of the version to be published. These points should be
stated
in the cover letter. If six or more authors are listed, the specific
contributions of each should be described in the cover letter.
Authors
are responsible for obtaining consent from human subjects
and the local ethics boards, and such consent should be
noted in the Materials
and Methods section of the manuscript.
Accepted manuscripts are presented to the Publisher to be
copyedited according to the house
style. Galley proofs are returned
to the corresponding author for final approval. Authors
are responsible for all statements made in
their work, including
changes made by the copy editor and authorized by the corresponding
author.
All authors must sign a statement of authorship responsibility
and copyright transfer prior to publication of their
paper. This form will be provided by the Formosan Medical
Association.
Publication Charges and Reprints
• The journal
will bear the cost of publication for articles of
5 printed pages or less for Original Articles, and 3 printed
pages or less for Case
Reports and Brief Communications.
Authors will be charged for the cost of the extra pages at
NT$4850/page.
• Authors
will be charged NT$2500 per illustration, figure or
table that is in color.
• Authors will receive 25 offprints of their
articles free of charge.
Additional professional reprints (which includes a cover
page for the article) may be ordered at terms based
on the cost
of production. A reprint order form will be provided by the
Publisher, together with the galley proofs.
Copyright
Published manuscripts become the permanent property of the
Publisher, Elsevier, and the Formosan Medical Association, and
may not be
published elsewhere, in any media and in any
language, without written permission. |
| |
|
